Anti-Transglutaminase 2 antibody [CUB 7402] (ab2386)

Publishing research using ab2386? Please let us know so that we can cite the reference in this datasheet.

ab2386 has been referenced in 8 publications.

  • Yang L  et al. GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2. Cancer Res 74:1022-31 (2014). PubMed: 24356421
  • Sánchez-Lara AC  et al. Feline Chronic Kidney Disease Is Associated With Upregulation of Transglutaminase 2: A Collagen Cross-Linking Enzyme. Vet Pathol N/A:N/A (2014). Cat . PubMed: 25047228
  • Pierce A  et al. Transglutaminase 2 expression in acute myeloid leukemia: Association with adhesion molecule expression and leukemic blast motility. Proteomics 13:2216-24 (2013). PubMed: 23576428
  • Jin T  et al. Expression TGM2 and BNIP3 have prognostic significance in laryngeal cancer patients receiving surgery and postoperative radiotherapy: a retrospective study. J Transl Med 10:64 (2012). IHC-P ; Human . PubMed: 22458929
  • Garrido-Gomez T  et al. Modeling Human Endometrial Decidualization from the Interaction between Proteome and Secretome. J Clin Endocrinol Metab : (2010). WB ; Human . PubMed: 21190976
  • Scarpellini A  et al. Heparan Sulfate Proteoglycans Are Receptors for the Cell-surface Trafficking and Biological Activity of Transglutaminase-2. J Biol Chem 284:18411-23 (2009). ICC/IF ; Mouse . PubMed: 19398782
  • Hartley DM  et al. Transglutaminase induces protofibril-like amyloid beta -protein assemblies that are protease-resistant and inhibit long-term potentiation. J Biol Chem : (2008). WB ; Guinea pig, Human . PubMed: 18397883
  • Amé-Thomas P  et al. Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis. Blood 109:693-702 (2007). ICC/IF ; Human . PubMed: 16985173

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"